Tetralone derivatives as antiarrhythmic agents
    12.
    发明授权
    Tetralone derivatives as antiarrhythmic agents 失效
    四烯酮衍生物作为抗心律失常药

    公开(公告)号:US6048877A

    公开(公告)日:2000-04-11

    申请号:US9812

    申请日:1998-01-20

    摘要: Tetralone derivatives of the formula ##STR1## where R.sup.1 is halo, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, (aryl)alkenyl, (aryl)alkynyl, alkoxy, O-alkenyl, O-aryl, O-alkyl(heterocyclo), COO-alkyl,alkanoyl, CO-amino, CO-substituted amino, alkyl-CO-amino, alkyl-CO-substituted amino, NHCO-alkyl, NHCO-aryl, NHCO-alkyl(heterocyclo), N(alkyl)CO-alkyl, N(alkyl)CO-aryl, N(alkyl)CO-heterocyclo, N(alkyl)CO-alkyl(heterocyclo);R.sup.2 is hydrogen, alkyl, halo, aryl, alkoxy, amino, substituted amino;R.sup.3 is oxo, hydroxy, alkoxy, O--COalkyl, --O--COaryl, --O--COheterocyclo, NOH, NO-alkyl, N-amino, N-substituted amino, N-NHCONHalkyl, N-NHSO.sub.2 alkyl, N-NHSO.sub.2 aryl, amino, substituted amino, NHCO-alkyl, NHCO-aryl, NHCO-heterocyclo, spiroheterocyclo;R.sup.4 is hydrogen, alkyl, alkyl(COalkyl), alkyl(COOalkyl); orR.sup.3 and R.sup.4 taken together with the atoms to which they are attached form a five- to seven-membered ring which can contain up to three heteroatoms selected from oxygen, nitrogen and sulfur;R.sup.5 is hydrogen, alkyl, alkenyl, alkyl(heterocyclo), alkyl-NHCO(alkyl), alkyl-NHCO(aryl), alkyl-NHCO(heterocyclo), alkyl-NHCO(alkylheterocyclo); andn is an integer of 0 to 2. These compounds have been found to be useful in the treatment of arrhythmia.

    摘要翻译: 下式的四氢萘酮衍生物其中R1是卤素,烷基,烯基,炔基,环烷基,芳基,(芳基)烯基,(芳基)炔基,烷氧基,O-烯基,O-芳基,O-烷基(杂环) ,烷基-CO-氨基,烷基-CO-取代的氨基,NHCO-烷基,NHCO-芳基,NHCO-烷基(杂环),N(烷基)CO-烷基,N( 烷基)CO-芳基,N(烷基)CO-杂环,N(烷基)CO-烷基(杂环); R2是氢,烷基,卤素,芳基,烷氧基,氨基,取代的氨基; R 3是氧代,羟基,烷氧基,O-CO烷基,-O-杂芳基,-O-杂环,NOH,NO-烷基,N-氨基,N-取代氨基,N-NHCONH烷基,N-NHSO2烷基,N-NHSO2芳基,氨基 取代氨基,NHCO-烷基,NHCO-芳基,NHCO-杂环,螺杂环; R4是氢,烷基,烷基(CO烷基),烷基(COO烷基); 或者R 3和R 4与它们所连接的原子一起形成五至七元环,其可含有至多三个选自氧,氮和硫的杂原子; R5是氢,烷基,烯基,烷基(杂环),烷基-NHCO(烷基),烷基-NHCO(芳基),烷基-NHCO(杂环),烷基-NHCO(烷基杂环) 并且n是0至2的整数。已经发现这些化合物可用于治疗心律失常。

    Phenylglycine and phenylalaninen amido benzopyran derivatives
    13.
    发明授权
    Phenylglycine and phenylalaninen amido benzopyran derivatives 失效
    苯基甘氨酸和苯丙氨酸酰氨基苯并吡喃衍生物

    公开(公告)号:US5612370A

    公开(公告)日:1997-03-18

    申请号:US484765

    申请日:1995-06-07

    申请人: Karnail S. Atwal

    发明人: Karnail S. Atwal

    CPC分类号: C07D311/70

    摘要: Compounds having the formula ##STR1## and pharmaceutically acceptable salts thereof wherein a, b and d are all carbon atoms or one of a, b and d is a nitrogen atom or --N(O)-- and the others are carbon atoms; Y is a single bond, --CH.sub.2 --, --C(O)--, --O--, --S-- or --N(R.sup.8)--; and R.sup.1 to R.sup.7 are as defined herein. These compounds have potassium channel activating activity and are useful, therefore for example, as cardiovascular agents.

    摘要翻译: 具有式I的化合物及其药学上可接受的盐,其中a,b和d都是碳原子,或a,b和d之一是氮原子或-N(O) - ,其余是碳原子; Y是单键,-CH 2 - , - C(O) - , - O - , - S-或-N(R 8) - 。 并且R 1至R 7如本文所定义。 这些化合物具有钾通道活化活性,因此可用作例如心血管剂。

    Lactam derivatives as antiarrhythmic agents
    15.
    发明授权
    Lactam derivatives as antiarrhythmic agents 有权
    内酰胺衍生物作为抗心律失常药

    公开(公告)号:US06664250B2

    公开(公告)日:2003-12-16

    申请号:US10267466

    申请日:2002-10-09

    IPC分类号: C07D48700

    摘要: Lactam derivatives of the formula where X is —C(═O)NR3′—, —NR3′C(═O)—, —C(═NCN)NR3′—, —NR3′C(═NCN)—, —CH2NR3′—, —CH(alkyl)NR3′—, —CH(COOalkyl)NR3′—, —CH(CH2OH)NR3′—, —C(CH2Oalkyl)—; R1 is halo, alkyl, cycloalkyl, alkyl(cycloalkyl), aryl, (aryl)alkyl, (aryl)alkenyl, (aryl)alkynyl, O-alkyl, O-alkenyl, O-aryl, O-alky(aryl), O-alkyl(heterocyclo), COO-alkyl, C)-alkyl, CO-amino, CO-substituted amino, alkyl-CO-amino, alkyl-CO-substituted amino, NHCO-alkyl, NHCO-aryl, NHCO-alkyl(aryl), NHCO-alkyl(heterocyclo), N(alkyl)CO-alkyl, N(alkyl)CO-aryl, N(alkyl)CO-heterocyclo, N(alkyl)CO-alkyl(aryl), N(alkyl)CO-alkyl(heterocyclo); R2 is hydrogen, alkyl, halo, aryl, (aryl)alkyl, O-alkyl, amino, substituted amino; R3 and R3′ are the same or different and are independently selected from hydrogen, alkyl or alkyl(aryl); R4 which can be bonded to a ring carbon or nitrogen, is selected from hydrogen, alkyl, alkenyl, alky(aryl), alkyl(heterocyclo), cycloalkyl, alkyl(cycloalkyl), alkyl-(amino), alkyl-(substituted amino), alkyl-NHCO(alkyl), alkyl-NHCO(aryl), alkyl-NHCO(heterocyclo), alkyl-NHCO(alkylaryl), alkyl-NHCO(alkylheterocyclo); and n is an integer of 0 to 2. These compounds have been found to be useful in the treatment of arrhythmia.

    摘要翻译: 式(2)的内酰胺衍生物是-C(= O)NR 3 - ,-NR 3 C(= O) - , - C(= NCN)NR 3 - C(= NCN) - , - CH 2 NR 3 - , - CH(烷基)NR 3 - , - CH(COO烷基)NR 3 - , - CH(CH 2 OH)NR 3 - , - C(CH 2 O烷基) - ; R 1是卤素,烷基,环烷基,烷基(环烷基),芳基,(芳基)烷基,(芳基)烯基,(芳基)炔基,O-烷基,O-链烯基, O-芳基,O-烷基(芳基),O-烷基(杂环),COO-烷基,C) - 烷基,CO-氨基,CO取代的氨基,烷基-CO-氨基,烷基-CO-取代的氨基,NHCO - 烷基,NHCO-芳基,NHCO-烷基(芳基),NHCO-烷基(杂环),N(烷基)CO-烷基,N(烷基)CO-芳基,N(烷基)CO-杂环,N(烷基) - 烷基(芳基),N(烷基)CO-烷基(杂环); R 2是氢,烷基,卤素,芳基,(芳基)烷基,O-烷基,氨基,取代的氨基; R 3和R “3”可以相同或不同,独立地选自氢,烷基或烷基(芳基);可以与环碳或氮键合的R 4选自氢,烷基,烯基,烷基(芳基 ),烷基(杂环),环烷基,烷基(环烷基),烷基 - (氨基) (烷基),烷基-NHCO(芳基),烷基-NHCO(杂环),烷基-NHCO(烷基芳基),烷基-NHCO(烷基杂环))。 并且n是0至2的整数。已经发现这些化合物可用于治疗心律失常。